ArticleProceedings of the National Academy of Sciences of the United States of America2026

AI-derived therapeutic development of a serotonin receptor-targeting drug for the treatment of opioid use disorder.

Valeria Lallai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.